Cytosorbents

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytosorbents and other ETFs, options, and stocks.

About CTSO

CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb.

CEO

Phillip P. Chan

CEOPhillip P. Chan

Employees

149

Employees149

Headquarters

Princeton, New Jersey

HeadquartersPrinceton, New Jersey

Founded

1997

Founded1997

Employees

149

Employees149

CTSO Key Statistics

Market cap

51.65M

Market cap51.65M

Price-Earnings ratio

-2.94

Price-Earnings ratio-2.94

Dividend yield

—

Dividend yield—

Average volume

88.75K

Average volume88.75K

High today

$0.8999

High today$0.8999

Low today

$0.81

Low today$0.81

Open price

$0.8488

Open price$0.8488

Volume

217.40K

Volume217.40K

52 Week high

$1.61

52 Week high$1.61

52 Week low

$0.70

52 Week low$0.70

People also own

Based on the portfolios of people who own CTSO. This list is generated using Robinhood data, and it’s not a recommendation.